

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.08163354 |
| 2 | GDP-mannose metabolic process (GO:0019673) | 5.22797398 |
| 3 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.89847370 |
| 4 | DNA strand elongation (GO:0022616) | 4.74286876 |
| 5 | DNA deamination (GO:0045006) | 4.65601776 |
| 6 | histone H4-K12 acetylation (GO:0043983) | 4.49320548 |
| 7 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.45146641 |
| 8 | maintenance of protein location in nucleus (GO:0051457) | 4.41693587 |
| 9 | pteridine-containing compound biosynthetic process (GO:0042559) | 4.38334502 |
| 10 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.37300109 |
| 11 | cytidine deamination (GO:0009972) | 4.37101706 |
| 12 | cytidine metabolic process (GO:0046087) | 4.37101706 |
| 13 | cytidine catabolic process (GO:0006216) | 4.37101706 |
| 14 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.33929400 |
| 15 | rRNA transcription (GO:0009303) | 4.31046238 |
| 16 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 4.28507227 |
| 17 | regulation of cilium movement (GO:0003352) | 4.21517824 |
| 18 | telomere maintenance via recombination (GO:0000722) | 4.19341760 |
| 19 | cullin deneddylation (GO:0010388) | 4.17386170 |
| 20 | rRNA methylation (GO:0031167) | 4.15531172 |
| 21 | protein deneddylation (GO:0000338) | 4.08898924 |
| 22 | proteasome assembly (GO:0043248) | 4.04607178 |
| 23 | somite rostral/caudal axis specification (GO:0032525) | 4.04581208 |
| 24 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.03745462 |
| 25 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.99225005 |
| 26 | negative regulation of epidermis development (GO:0045683) | 3.96537932 |
| 27 | mitotic recombination (GO:0006312) | 3.93847794 |
| 28 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.91760681 |
| 29 | mitotic chromosome condensation (GO:0007076) | 3.90622981 |
| 30 | sister chromatid segregation (GO:0000819) | 3.89021710 |
| 31 | establishment of integrated proviral latency (GO:0075713) | 3.86199799 |
| 32 | maintenance of protein localization in organelle (GO:0072595) | 3.85408523 |
| 33 | COPI coating of Golgi vesicle (GO:0048205) | 3.83125843 |
| 34 | Golgi transport vesicle coating (GO:0048200) | 3.83125843 |
| 35 | histone H4-K5 acetylation (GO:0043981) | 3.81306298 |
| 36 | histone H4-K8 acetylation (GO:0043982) | 3.81306298 |
| 37 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.80569862 |
| 38 | negative regulation of telomerase activity (GO:0051974) | 3.80226290 |
| 39 | rRNA modification (GO:0000154) | 3.78892908 |
| 40 | CENP-A containing nucleosome assembly (GO:0034080) | 3.77893454 |
| 41 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.76501535 |
| 42 | protein localization to kinetochore (GO:0034501) | 3.74782612 |
| 43 | negative regulation of phagocytosis (GO:0050765) | 3.73514492 |
| 44 | quinone metabolic process (GO:1901661) | 3.71698598 |
| 45 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.71126118 |
| 46 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.68655661 |
| 47 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.66695863 |
| 48 | chromatin remodeling at centromere (GO:0031055) | 3.61527949 |
| 49 | muscle organ morphogenesis (GO:0048644) | 3.60381600 |
| 50 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.60279009 |
| 51 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.58642280 |
| 52 | signal peptide processing (GO:0006465) | 3.57653541 |
| 53 | coenzyme catabolic process (GO:0009109) | 3.55541829 |
| 54 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.55238006 |
| 55 | hormone catabolic process (GO:0042447) | 3.53702171 |
| 56 | proline biosynthetic process (GO:0006561) | 3.51498875 |
| 57 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.49901128 |
| 58 | valine metabolic process (GO:0006573) | 3.49763917 |
| 59 | DNA replication checkpoint (GO:0000076) | 3.47671591 |
| 60 | formation of translation preinitiation complex (GO:0001731) | 3.47223278 |
| 61 | mitotic metaphase plate congression (GO:0007080) | 3.45886127 |
| 62 | regulation of response to osmotic stress (GO:0047484) | 3.44340663 |
| 63 | negative regulation of telomere maintenance (GO:0032205) | 3.40563486 |
| 64 | pseudouridine synthesis (GO:0001522) | 3.39573838 |
| 65 | protein maturation by protein folding (GO:0022417) | 3.39337912 |
| 66 | regulation of mitochondrial translation (GO:0070129) | 3.38505747 |
| 67 | negative regulation of ligase activity (GO:0051352) | 3.38118506 |
| 68 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.38118506 |
| 69 | ribosomal small subunit assembly (GO:0000028) | 3.33590316 |
| 70 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.31355442 |
| 71 | DNA ligation (GO:0006266) | 3.30576275 |
| 72 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.23011992 |
| 73 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.21926521 |
| 74 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.20021873 |
| 75 | primitive streak formation (GO:0090009) | 3.19568635 |
| 76 | nucleoside transmembrane transport (GO:1901642) | 3.19231382 |
| 77 | purine nucleobase biosynthetic process (GO:0009113) | 3.18800463 |
| 78 | regulation of mitotic spindle organization (GO:0060236) | 3.17959203 |
| 79 | response to dietary excess (GO:0002021) | 3.17956262 |
| 80 | transcription from mitochondrial promoter (GO:0006390) | 3.17152074 |
| 81 | metaphase plate congression (GO:0051310) | 3.15228348 |
| 82 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.14845274 |
| 83 | interferon-gamma production (GO:0032609) | 3.13564971 |
| 84 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.10238495 |
| 85 | regulation of spindle organization (GO:0090224) | 3.09871457 |
| 86 | positive regulation of protein deacetylation (GO:0090312) | 3.09194850 |
| 87 | telomere maintenance via telomere lengthening (GO:0010833) | 3.06538206 |
| 88 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.05707274 |
| 89 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.05707274 |
| 90 | ATP synthesis coupled proton transport (GO:0015986) | 3.05676536 |
| 91 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.05676536 |
| 92 | establishment of viral latency (GO:0019043) | 3.05407319 |
| 93 | ribosome biogenesis (GO:0042254) | 3.04847714 |
| 94 | protein K6-linked ubiquitination (GO:0085020) | 3.04798648 |
| 95 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.04763255 |
| 96 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.04737789 |
| 97 | kinetochore organization (GO:0051383) | 3.04675873 |
| 98 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.04457771 |
| 99 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.04457771 |
| 100 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.04457771 |
| 101 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.03461410 |
| 102 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.03461410 |
| 103 | regulation of translation in response to stress (GO:0043555) | 3.02747484 |
| 104 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.02169599 |
| 105 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.02169599 |
| 106 | mitochondrial DNA replication (GO:0006264) | 3.01963829 |
| 107 | glycoside metabolic process (GO:0016137) | 3.01202439 |
| 108 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.00980928 |
| 109 | regulation of sister chromatid cohesion (GO:0007063) | 3.00802577 |
| 110 | tricarboxylic acid cycle (GO:0006099) | 3.00221021 |
| 111 | L-serine metabolic process (GO:0006563) | 2.97918250 |
| 112 | cellular modified amino acid catabolic process (GO:0042219) | 2.96637420 |
| 113 | protein retention in ER lumen (GO:0006621) | 2.96351339 |
| 114 | ribosome assembly (GO:0042255) | 2.95375032 |
| 115 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.95252424 |
| 116 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.92676888 |
| 117 | folic acid metabolic process (GO:0046655) | 2.92553720 |
| 118 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.91671499 |
| 119 | GMP metabolic process (GO:0046037) | 2.90756347 |
| 120 | non-recombinational repair (GO:0000726) | 2.89380145 |
| 121 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.89380145 |
| 122 | nucleobase biosynthetic process (GO:0046112) | 2.88507292 |
| 123 | positive regulation of ligase activity (GO:0051351) | 2.88085831 |
| 124 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.88052644 |
| 125 | cell cycle G1/S phase transition (GO:0044843) | 2.87824098 |
| 126 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.87824098 |
| 127 | protein neddylation (GO:0045116) | 2.85958511 |
| 128 | DNA replication initiation (GO:0006270) | 2.85681061 |
| 129 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.85272406 |
| 130 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.84925178 |
| 131 | phenol-containing compound catabolic process (GO:0019336) | 2.83829528 |
| 132 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.80866235 |
| 133 | DNA replication-independent nucleosome organization (GO:0034724) | 2.80866235 |
| 134 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.78310734 |
| 135 | histone exchange (GO:0043486) | 2.76350100 |
| 136 | respiratory electron transport chain (GO:0022904) | 2.74878125 |
| 137 | mitotic sister chromatid segregation (GO:0000070) | 2.74336696 |
| 138 | thyroid hormone generation (GO:0006590) | 2.74234671 |
| 139 | NADH metabolic process (GO:0006734) | 2.73955965 |
| 140 | heparin biosynthetic process (GO:0030210) | 2.73331224 |
| 141 | heparin metabolic process (GO:0030202) | 2.73331224 |
| 142 | protein localization to cilium (GO:0061512) | 2.73006420 |
| 143 | regulation of ligase activity (GO:0051340) | 2.71999590 |
| 144 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.71589819 |
| 145 | chromosome condensation (GO:0030261) | 2.71311657 |
| 146 | electron transport chain (GO:0022900) | 2.71047882 |
| 147 | establishment of chromosome localization (GO:0051303) | 2.70982027 |
| 148 | protein polyglutamylation (GO:0018095) | 2.69932688 |
| 149 | positive regulation of chromosome segregation (GO:0051984) | 2.69843033 |
| 150 | branched-chain amino acid catabolic process (GO:0009083) | 2.69409529 |
| 151 | nucleotide-sugar metabolic process (GO:0009225) | 2.68460646 |
| 152 | tetrahydrofolate metabolic process (GO:0046653) | 2.68416107 |
| 153 | pteridine-containing compound metabolic process (GO:0042558) | 2.68237876 |
| 154 | oxidative phosphorylation (GO:0006119) | 2.68081796 |
| 155 | protein targeting to mitochondrion (GO:0006626) | 2.66301491 |
| 156 | DNA unwinding involved in DNA replication (GO:0006268) | 2.65241623 |
| 157 | negative regulation of interleukin-2 production (GO:0032703) | 2.65210167 |
| 158 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.65102562 |
| 159 | regulation of microtubule-based movement (GO:0060632) | 2.64070042 |
| 160 | IMP biosynthetic process (GO:0006188) | 2.63440635 |
| 161 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.62453517 |
| 162 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.62099584 |
| 163 | serine family amino acid biosynthetic process (GO:0009070) | 2.61534029 |
| 164 | immunoglobulin mediated immune response (GO:0016064) | 2.60161759 |
| 165 | protein localization to chromosome, centromeric region (GO:0071459) | 2.59767515 |
| 166 | melanosome transport (GO:0032402) | 2.56343371 |
| 167 | regulation of telomerase activity (GO:0051972) | 2.54317601 |
| 168 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.54172207 |
| 169 | megakaryocyte development (GO:0035855) | 2.53092088 |
| 170 | histone H4-K16 acetylation (GO:0043984) | 2.51785471 |
| 171 | endosome to pigment granule transport (GO:0043485) | 2.51444851 |
| 172 | endosome to melanosome transport (GO:0035646) | 2.51444851 |
| 173 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.51353260 |
| 174 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.51353260 |
| 175 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.49007799 |
| 176 | mitochondrion distribution (GO:0048311) | 2.47337336 |
| 177 | cofactor catabolic process (GO:0051187) | 2.47303643 |
| 178 | cofactor transport (GO:0051181) | 2.45025300 |
| 179 | biotin metabolic process (GO:0006768) | 2.44519855 |
| 180 | branched-chain amino acid metabolic process (GO:0009081) | 2.42813495 |
| 181 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.41704348 |
| 182 | sulfur amino acid catabolic process (GO:0000098) | 2.39415598 |
| 183 | daunorubicin metabolic process (GO:0044597) | 10.8547478 |
| 184 | polyketide metabolic process (GO:0030638) | 10.8547478 |
| 185 | doxorubicin metabolic process (GO:0044598) | 10.8547478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 5.41232611 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.53415512 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.13484439 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.70098835 |
| 5 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.26824552 |
| 6 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.12038716 |
| 7 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.12038716 |
| 8 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.12038716 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.05161570 |
| 10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.99850369 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.53964163 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.52945740 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.41482211 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.33401219 |
| 15 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.26571241 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.19321969 |
| 17 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.11755876 |
| 18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.11504442 |
| 19 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.08217322 |
| 20 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.08197677 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.99767782 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.96271282 |
| 23 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.95355707 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.93968415 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 1.93432471 |
| 26 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.90640785 |
| 27 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.90369628 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.82814651 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.82778101 |
| 30 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.81308957 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81116892 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.79033092 |
| 33 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.78628706 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77845490 |
| 35 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.77683259 |
| 36 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.76502242 |
| 37 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.71721482 |
| 38 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.71273200 |
| 39 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.71052505 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.70147523 |
| 41 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.68835446 |
| 42 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.67316456 |
| 43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66987697 |
| 44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.63749974 |
| 45 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.62333385 |
| 46 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.62102117 |
| 47 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.61834001 |
| 48 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.60380150 |
| 49 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59971304 |
| 50 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.58915400 |
| 51 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.58914050 |
| 52 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.57185835 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.57094683 |
| 54 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.55612428 |
| 55 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.54208769 |
| 56 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.53126691 |
| 57 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.50882591 |
| 58 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.46327138 |
| 59 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.44359494 |
| 60 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.43448593 |
| 61 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.42884994 |
| 62 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42285756 |
| 63 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.39807086 |
| 64 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.37535814 |
| 65 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.36083539 |
| 66 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.35156454 |
| 67 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.34285682 |
| 68 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.33115497 |
| 69 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.31925220 |
| 70 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.31017626 |
| 71 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.30566646 |
| 72 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.29865918 |
| 73 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.26189775 |
| 74 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.24459451 |
| 75 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.24245327 |
| 76 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.24101179 |
| 77 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.23852670 |
| 78 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.23178139 |
| 79 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.22997175 |
| 80 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.22967990 |
| 81 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.19082182 |
| 82 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.17670965 |
| 83 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.17541790 |
| 84 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.17305251 |
| 85 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16141302 |
| 86 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15469522 |
| 87 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13801812 |
| 88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.12228780 |
| 89 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.11571022 |
| 90 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11493668 |
| 91 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.11118051 |
| 92 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.11008715 |
| 93 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.10792876 |
| 94 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.10462033 |
| 95 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.09688047 |
| 96 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.09456971 |
| 97 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08759935 |
| 98 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.07424647 |
| 99 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.06873512 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04728954 |
| 101 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04163618 |
| 102 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.03076536 |
| 103 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.02946915 |
| 104 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02360957 |
| 105 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00484082 |
| 106 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.00344543 |
| 107 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.00024141 |
| 108 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99908691 |
| 109 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.99293372 |
| 110 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.99083249 |
| 111 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.98797828 |
| 112 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.98633577 |
| 113 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98446290 |
| 114 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98298840 |
| 115 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.98026415 |
| 116 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97694016 |
| 117 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96877637 |
| 118 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96503262 |
| 119 | * E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.96497434 |
| 120 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95639240 |
| 121 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.95403668 |
| 122 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.92638861 |
| 123 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92063044 |
| 124 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91773544 |
| 125 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.90969533 |
| 126 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90656848 |
| 127 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.90429340 |
| 128 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90423062 |
| 129 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.89244618 |
| 130 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89221393 |
| 131 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.88648455 |
| 132 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88064742 |
| 133 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.87222065 |
| 134 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.84916711 |
| 135 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.81104110 |
| 136 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.80340469 |
| 137 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.79490968 |
| 138 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79456358 |
| 139 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.77233495 |
| 140 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.76986120 |
| 141 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.76717649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 4.59800393 |
| 2 | MP0006292_abnormal_olfactory_placode | 4.18912217 |
| 3 | MP0003111_abnormal_nucleus_morphology | 3.75406188 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 3.69109977 |
| 5 | MP0005075_abnormal_melanosome_morpholog | 3.56727616 |
| 6 | MP0003183_abnormal_peptide_metabolism | 3.56432741 |
| 7 | MP0008932_abnormal_embryonic_tissue | 3.04957028 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 2.65996754 |
| 9 | MP0000678_abnormal_parathyroid_gland | 2.62181486 |
| 10 | MP0004957_abnormal_blastocyst_morpholog | 2.62136942 |
| 11 | MP0002254_reproductive_system_inflammat | 2.59416550 |
| 12 | MP0005360_urolithiasis | 2.58018163 |
| 13 | MP0009697_abnormal_copulation | 2.57801479 |
| 14 | MP0003122_maternal_imprinting | 2.55227415 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.53496350 |
| 16 | MP0010352_gastrointestinal_tract_polyps | 2.47685365 |
| 17 | MP0008057_abnormal_DNA_replication | 2.40282919 |
| 18 | MP0005408_hypopigmentation | 2.36243245 |
| 19 | MP0005394_taste/olfaction_phenotype | 2.35179403 |
| 20 | MP0005499_abnormal_olfactory_system | 2.35179403 |
| 21 | MP0002653_abnormal_ependyma_morphology | 2.14594909 |
| 22 | MP0000537_abnormal_urethra_morphology | 2.09590532 |
| 23 | MP0003718_maternal_effect | 2.07795551 |
| 24 | MP0001346_abnormal_lacrimal_gland | 2.02986581 |
| 25 | MP0001986_abnormal_taste_sensitivity | 1.95621073 |
| 26 | MP0008007_abnormal_cellular_replicative | 1.94153912 |
| 27 | MP0003123_paternal_imprinting | 1.92697818 |
| 28 | MP0002877_abnormal_melanocyte_morpholog | 1.89053434 |
| 29 | MP0005257_abnormal_intraocular_pressure | 1.88527339 |
| 30 | MP0003890_abnormal_embryonic-extraembry | 1.85721698 |
| 31 | MP0004043_abnormal_pH_regulation | 1.83924632 |
| 32 | MP0003186_abnormal_redox_activity | 1.74020870 |
| 33 | MP0000490_abnormal_crypts_of | 1.72065610 |
| 34 | MP0006035_abnormal_mitochondrial_morpho | 1.71399089 |
| 35 | MP0004147_increased_porphyrin_level | 1.65195011 |
| 36 | MP0003315_abnormal_perineum_morphology | 1.64873833 |
| 37 | MP0002938_white_spotting | 1.63877694 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.61405189 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.60467558 |
| 40 | MP0002332_abnormal_exercise_endurance | 1.57560806 |
| 41 | MP0002132_abnormal_respiratory_system | 1.55037033 |
| 42 | MP0003121_genomic_imprinting | 1.53646820 |
| 43 | MP0001730_embryonic_growth_arrest | 1.49228888 |
| 44 | MP0004858_abnormal_nervous_system | 1.48008378 |
| 45 | MP0001661_extended_life_span | 1.47037925 |
| 46 | MP0010030_abnormal_orbit_morphology | 1.45584942 |
| 47 | MP0005501_abnormal_skin_physiology | 1.45052476 |
| 48 | MP0005220_abnormal_exocrine_pancreas | 1.39956444 |
| 49 | MP0005365_abnormal_bile_salt | 1.38971484 |
| 50 | MP0003077_abnormal_cell_cycle | 1.37228851 |
| 51 | MP0001835_abnormal_antigen_presentation | 1.36742859 |
| 52 | MP0002970_abnormal_white_adipose | 1.33381597 |
| 53 | MP0002909_abnormal_adrenal_gland | 1.31946792 |
| 54 | MP0001697_abnormal_embryo_size | 1.30693732 |
| 55 | MP0008961_abnormal_basal_metabolism | 1.28687527 |
| 56 | MP0001666_abnormal_nutrient_absorption | 1.27408778 |
| 57 | MP0005671_abnormal_response_to | 1.26774938 |
| 58 | MP0005171_absent_coat_pigmentation | 1.25976945 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.25814589 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.25814589 |
| 61 | MP0004808_abnormal_hematopoietic_stem | 1.25493006 |
| 62 | MP0005266_abnormal_metabolism | 1.22272510 |
| 63 | MP0000372_irregular_coat_pigmentation | 1.22116837 |
| 64 | MP0009379_abnormal_foot_pigmentation | 1.21449439 |
| 65 | MP0010307_abnormal_tumor_latency | 1.19639075 |
| 66 | MP0000358_abnormal_cell_content/ | 1.18987091 |
| 67 | MP0002234_abnormal_pharynx_morphology | 1.16759464 |
| 68 | MP0006082_CNS_inflammation | 1.15382824 |
| 69 | MP0008789_abnormal_olfactory_epithelium | 1.14689614 |
| 70 | MP0003693_abnormal_embryo_hatching | 1.13462709 |
| 71 | MP0005248_abnormal_Harderian_gland | 1.12562628 |
| 72 | MP0002080_prenatal_lethality | 1.12545381 |
| 73 | MP0005332_abnormal_amino_acid | 1.12279072 |
| 74 | MP0001944_abnormal_pancreas_morphology | 1.12111773 |
| 75 | MP0003763_abnormal_thymus_physiology | 1.10212543 |
| 76 | MP0000689_abnormal_spleen_morphology | 1.09437072 |
| 77 | MP0000313_abnormal_cell_death | 1.07982721 |
| 78 | MP0008058_abnormal_DNA_repair | 1.07901699 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 1.07349956 |
| 80 | MP0002693_abnormal_pancreas_physiology | 1.07039496 |
| 81 | MP0005379_endocrine/exocrine_gland_phen | 1.06203444 |
| 82 | MP0001293_anophthalmia | 1.06167234 |
| 83 | MP0001881_abnormal_mammary_gland | 1.04457129 |
| 84 | MP0010094_abnormal_chromosome_stability | 1.02582329 |
| 85 | MP0002160_abnormal_reproductive_system | 1.01180201 |
| 86 | MP0002722_abnormal_immune_system | 1.00369259 |
| 87 | MP0002098_abnormal_vibrissa_morphology | 0.99938506 |
| 88 | MP0001727_abnormal_embryo_implantation | 0.99373319 |
| 89 | MP0001270_distended_abdomen | 0.99044674 |
| 90 | MP0002019_abnormal_tumor_incidence | 0.97096390 |
| 91 | MP0001984_abnormal_olfaction | 0.96540832 |
| 92 | MP0003191_abnormal_cellular_cholesterol | 0.96059641 |
| 93 | MP0000516_abnormal_urinary_system | 0.96007490 |
| 94 | MP0005367_renal/urinary_system_phenotyp | 0.96007490 |
| 95 | MP0002163_abnormal_gland_morphology | 0.95758759 |
| 96 | MP0009780_abnormal_chondrocyte_physiolo | 0.94909788 |
| 97 | MP0004233_abnormal_muscle_weight | 0.94862220 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.94196967 |
| 99 | MP0003786_premature_aging | 0.93555591 |
| 100 | MP0005187_abnormal_penis_morphology | 0.92600651 |
| 101 | MP0002697_abnormal_eye_size | 0.92576762 |
| 102 | MP0002085_abnormal_embryonic_tissue | 0.92434967 |
| 103 | MP0000627_abnormal_mammary_gland | 0.91111281 |
| 104 | MP0000685_abnormal_immune_system | 0.90052408 |
| 105 | MP0002398_abnormal_bone_marrow | 0.89820196 |
| 106 | MP0002139_abnormal_hepatobiliary_system | 0.89210347 |
| 107 | MP0003806_abnormal_nucleotide_metabolis | 0.89177378 |
| 108 | MP0000566_synostosis | 0.88884106 |
| 109 | MP0002210_abnormal_sex_determination | 0.88180821 |
| 110 | MP0000350_abnormal_cell_proliferation | 0.87589388 |
| 111 | MP0003136_yellow_coat_color | 0.86225647 |
| 112 | MP0001529_abnormal_vocalization | 0.86027614 |
| 113 | MP0008995_early_reproductive_senescence | 0.85659493 |
| 114 | MP0005253_abnormal_eye_physiology | 0.85344247 |
| 115 | MP0002084_abnormal_developmental_patter | 0.84676272 |
| 116 | MP0000465_gastrointestinal_hemorrhage | 0.84527644 |
| 117 | MP0002928_abnormal_bile_duct | 0.84056294 |
| 118 | MP0002429_abnormal_blood_cell | 0.83917373 |
| 119 | MP0000858_altered_metastatic_potential | 0.83858831 |
| 120 | MP0008875_abnormal_xenobiotic_pharmacok | 0.83718634 |
| 121 | MP0000538_abnormal_urinary_bladder | 0.83108449 |
| 122 | MP0002075_abnormal_coat/hair_pigmentati | 0.82260999 |
| 123 | MP0010678_abnormal_skin_adnexa | 0.82225500 |
| 124 | MP0005085_abnormal_gallbladder_physiolo | 0.81628127 |
| 125 | MP0001849_ear_inflammation | 0.79743073 |
| 126 | MP0005380_embryogenesis_phenotype | 0.78828181 |
| 127 | MP0001672_abnormal_embryogenesis/_devel | 0.78828181 |
| 128 | MP0001145_abnormal_male_reproductive | 0.78792468 |
| 129 | MP0002088_abnormal_embryonic_growth/wei | 0.78689274 |
| 130 | MP0001919_abnormal_reproductive_system | 0.78460964 |
| 131 | MP0003283_abnormal_digestive_organ | 0.78249544 |
| 132 | MP0003937_abnormal_limbs/digits/tail_de | 0.78175438 |
| 133 | MP0000598_abnormal_liver_morphology | 0.78055447 |
| 134 | MP0000647_abnormal_sebaceous_gland | 0.78017817 |
| 135 | MP0003984_embryonic_growth_retardation | 0.77644074 |
| 136 | MP0002078_abnormal_glucose_homeostasis | 0.77569386 |
| 137 | MP0001929_abnormal_gametogenesis | 0.77101719 |
| 138 | MP0001764_abnormal_homeostasis | 0.76491710 |
| 139 | MP0009785_altered_susceptibility_to | 0.75520934 |
| 140 | MP0000716_abnormal_immune_system | 0.75509160 |
| 141 | MP0005310_abnormal_salivary_gland | 0.75370297 |
| 142 | MP0000653_abnormal_sex_gland | 0.74576367 |
| 143 | MP0000613_abnormal_salivary_gland | 0.74220580 |
| 144 | MP0001853_heart_inflammation | 0.74176215 |
| 145 | MP0009643_abnormal_urine_homeostasis | 0.73897835 |
| 146 | MP0009333_abnormal_splenocyte_physiolog | 0.73816960 |
| 147 | MP0000013_abnormal_adipose_tissue | 0.73790311 |
| 148 | MP0002127_abnormal_cardiovascular_syste | 0.73325654 |
| 149 | MP0004019_abnormal_vitamin_homeostasis | 0.72481787 |
| 150 | MP0002751_abnormal_autonomic_nervous | 0.71608998 |
| 151 | MP0010368_abnormal_lymphatic_system | 0.71311047 |
| 152 | MP0000609_abnormal_liver_physiology | 0.70122512 |
| 153 | MP0002405_respiratory_system_inflammati | 0.69985556 |
| 154 | MP0002102_abnormal_ear_morphology | 0.69973608 |
| 155 | MP0005058_abnormal_lysosome_morphology | 0.69362502 |
| 156 | MP0003656_abnormal_erythrocyte_physiolo | 0.68737363 |
| 157 | MP0000343_altered_response_to | 0.68580999 |
| 158 | MP0005025_abnormal_response_to | 0.67847113 |
| 159 | MP0002736_abnormal_nociception_after | 0.67409892 |
| 160 | MP0000427_abnormal_hair_cycle | 0.66658206 |
| 161 | MP0005389_reproductive_system_phenotype | 0.66432396 |
| 162 | MP0005623_abnormal_meninges_morphology | 0.66208741 |
| 163 | MP0005636_abnormal_mineral_homeostasis | 0.65948687 |
| 164 | MP0002086_abnormal_extraembryonic_tissu | 0.65774614 |
| 165 | MP0002796_impaired_skin_barrier | 0.62271625 |
| 166 | MP0001756_abnormal_urination | 0.61777890 |
| 167 | MP0003943_abnormal_hepatobiliary_system | 0.61591945 |
| 168 | MP0000462_abnormal_digestive_system | 0.61410435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 5.05527263 |
| 2 | Reduced antithrombin III activity (HP:0001976) | 4.76094407 |
| 3 | Hepatoblastoma (HP:0002884) | 4.35760588 |
| 4 | Type I transferrin isoform profile (HP:0003642) | 4.18744510 |
| 5 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.16330413 |
| 6 | Aplastic anemia (HP:0001915) | 4.16194190 |
| 7 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.13474943 |
| 8 | Ragged-red muscle fibers (HP:0003200) | 4.07250974 |
| 9 | Multiple enchondromatosis (HP:0005701) | 3.80737172 |
| 10 | Abnormality of the intrinsic pathway (HP:0010989) | 3.74896671 |
| 11 | Abnormality of glycolysis (HP:0004366) | 3.72349263 |
| 12 | Chromsome breakage (HP:0040012) | 3.69582140 |
| 13 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.59299269 |
| 14 | Hypochromic microcytic anemia (HP:0004840) | 3.56296902 |
| 15 | Acute encephalopathy (HP:0006846) | 3.54515179 |
| 16 | Hypoplasia of the fovea (HP:0007750) | 3.54343560 |
| 17 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.54343560 |
| 18 | Hepatic necrosis (HP:0002605) | 3.52161611 |
| 19 | Increased serum pyruvate (HP:0003542) | 3.46989772 |
| 20 | Acute necrotizing encephalopathy (HP:0006965) | 3.46936840 |
| 21 | Bifid tongue (HP:0010297) | 3.37489921 |
| 22 | Hepatocellular necrosis (HP:0001404) | 3.22104558 |
| 23 | Abnormality of the lower motor neuron (HP:0002366) | 3.13699527 |
| 24 | Abnormal protein glycosylation (HP:0012346) | 3.12611855 |
| 25 | Abnormal glycosylation (HP:0012345) | 3.12611855 |
| 26 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.12611855 |
| 27 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.12611855 |
| 28 | Mitochondrial inheritance (HP:0001427) | 3.07221181 |
| 29 | Abnormality of the fovea (HP:0000493) | 3.05383170 |
| 30 | Increased CSF lactate (HP:0002490) | 3.03235722 |
| 31 | Cerebral edema (HP:0002181) | 2.98589058 |
| 32 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.94299695 |
| 33 | Single umbilical artery (HP:0001195) | 2.94299695 |
| 34 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.94299695 |
| 35 | Rib fusion (HP:0000902) | 2.89576311 |
| 36 | Microvesicular hepatic steatosis (HP:0001414) | 2.82043834 |
| 37 | Pendular nystagmus (HP:0012043) | 2.81868934 |
| 38 | Reticulocytopenia (HP:0001896) | 2.81419964 |
| 39 | Abnormality of the preputium (HP:0100587) | 2.79316551 |
| 40 | Abnormality of the umbilical cord (HP:0010881) | 2.75193074 |
| 41 | Microretrognathia (HP:0000308) | 2.73009892 |
| 42 | Progressive macrocephaly (HP:0004481) | 2.72763507 |
| 43 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.70745171 |
| 44 | Meckel diverticulum (HP:0002245) | 2.70496147 |
| 45 | 3-Methylglutaconic aciduria (HP:0003535) | 2.69107303 |
| 46 | Progressive muscle weakness (HP:0003323) | 2.66809596 |
| 47 | Ependymoma (HP:0002888) | 2.55557857 |
| 48 | Generalized aminoaciduria (HP:0002909) | 2.55357469 |
| 49 | Gout (HP:0001997) | 2.55199149 |
| 50 | Lactic acidosis (HP:0003128) | 2.55173056 |
| 51 | Abnormality of glycolipid metabolism (HP:0010969) | 2.53369241 |
| 52 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.53369241 |
| 53 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.53369241 |
| 54 | Abnormality of the ileum (HP:0001549) | 2.51542249 |
| 55 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.50387504 |
| 56 | Increased serum lactate (HP:0002151) | 2.49900118 |
| 57 | Nasal polyposis (HP:0100582) | 2.42096808 |
| 58 | Abnormality of chromosome stability (HP:0003220) | 2.40775283 |
| 59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.40652232 |
| 60 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.37505063 |
| 61 | Poor head control (HP:0002421) | 2.36138017 |
| 62 | Megaloblastic anemia (HP:0001889) | 2.35220004 |
| 63 | Tongue fasciculations (HP:0001308) | 2.34514568 |
| 64 | Spinal muscular atrophy (HP:0007269) | 2.34269850 |
| 65 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.32152785 |
| 66 | Proximal tubulopathy (HP:0000114) | 2.32022332 |
| 67 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.31589082 |
| 68 | Abnormality of methionine metabolism (HP:0010901) | 2.30257281 |
| 69 | Respiratory failure (HP:0002878) | 2.28572232 |
| 70 | Nausea (HP:0002018) | 2.27399915 |
| 71 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.26351230 |
| 72 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.25405536 |
| 73 | Increased hepatocellular lipid droplets (HP:0006565) | 2.23080574 |
| 74 | Exercise intolerance (HP:0003546) | 2.22788641 |
| 75 | Hyperammonemia (HP:0001987) | 2.21276346 |
| 76 | Abnormal lung lobation (HP:0002101) | 2.20039139 |
| 77 | Thrombocytosis (HP:0001894) | 2.19895227 |
| 78 | Hypokinesia (HP:0002375) | 2.18713427 |
| 79 | Testicular atrophy (HP:0000029) | 2.17228391 |
| 80 | Ketoacidosis (HP:0001993) | 2.15908884 |
| 81 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.15590764 |
| 82 | Villous atrophy (HP:0011473) | 2.15590764 |
| 83 | Hypothermia (HP:0002045) | 2.15454354 |
| 84 | Abnormality of T cell physiology (HP:0011840) | 2.13640468 |
| 85 | Cortical visual impairment (HP:0100704) | 2.13551733 |
| 86 | Abnormality of the nasal mucosa (HP:0000433) | 2.13259539 |
| 87 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.12839886 |
| 88 | Lethargy (HP:0001254) | 2.11870256 |
| 89 | Cholecystitis (HP:0001082) | 2.11632358 |
| 90 | Abnormal gallbladder physiology (HP:0012438) | 2.11632358 |
| 91 | Cutaneous melanoma (HP:0012056) | 2.10768463 |
| 92 | Duodenal stenosis (HP:0100867) | 2.10652500 |
| 93 | Small intestinal stenosis (HP:0012848) | 2.10652500 |
| 94 | Embryonal renal neoplasm (HP:0011794) | 2.08929227 |
| 95 | Rhabdomyosarcoma (HP:0002859) | 2.08219791 |
| 96 | Macrocytic anemia (HP:0001972) | 2.07405074 |
| 97 | Abnormality of the anterior horn cell (HP:0006802) | 2.06972155 |
| 98 | Degeneration of anterior horn cells (HP:0002398) | 2.06972155 |
| 99 | Partial duplication of thumb phalanx (HP:0009944) | 2.06662800 |
| 100 | Orthostatic hypotension (HP:0001278) | 2.06559904 |
| 101 | Neoplasm of striated muscle (HP:0009728) | 2.05137041 |
| 102 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.04323521 |
| 103 | Hyperventilation (HP:0002883) | 2.03879283 |
| 104 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.03447525 |
| 105 | Lipid accumulation in hepatocytes (HP:0006561) | 2.00887192 |
| 106 | Increased intramyocellular lipid droplets (HP:0012240) | 1.99736978 |
| 107 | Pancytopenia (HP:0001876) | 1.98665887 |
| 108 | Vaginal fistula (HP:0004320) | 1.98347237 |
| 109 | Congenital stationary night blindness (HP:0007642) | 1.97748237 |
| 110 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.96671896 |
| 111 | Myelodysplasia (HP:0002863) | 1.95888225 |
| 112 | Increased nuchal translucency (HP:0010880) | 1.94475123 |
| 113 | Overlapping toe (HP:0001845) | 1.94392472 |
| 114 | IgM deficiency (HP:0002850) | 1.94186075 |
| 115 | Broad foot (HP:0001769) | 1.92148029 |
| 116 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.91351723 |
| 117 | Trismus (HP:0000211) | 1.91147595 |
| 118 | Sparse eyelashes (HP:0000653) | 1.91130039 |
| 119 | Late onset (HP:0003584) | 1.90384513 |
| 120 | Renal Fanconi syndrome (HP:0001994) | 1.90330111 |
| 121 | Hypoglycemic seizures (HP:0002173) | 1.88371796 |
| 122 | Muscle fibrillation (HP:0010546) | 1.88097963 |
| 123 | Abnormal cartilage morphology (HP:0002763) | 1.87722577 |
| 124 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.87295956 |
| 125 | Rectovaginal fistula (HP:0000143) | 1.87237876 |
| 126 | Rectal fistula (HP:0100590) | 1.87237876 |
| 127 | Panhypogammaglobulinemia (HP:0003139) | 1.86815827 |
| 128 | Microglossia (HP:0000171) | 1.86397640 |
| 129 | Abnormal tarsal ossification (HP:0008369) | 1.86250480 |
| 130 | Abnormality of the carotid arteries (HP:0005344) | 1.85819861 |
| 131 | Hypoplasia of the thymus (HP:0000778) | 1.85762685 |
| 132 | Hypobetalipoproteinemia (HP:0003563) | 1.85572654 |
| 133 | Symptomatic seizures (HP:0011145) | 1.85289695 |
| 134 | Missing ribs (HP:0000921) | 1.84013798 |
| 135 | Abnormality of urine glucose concentration (HP:0011016) | 1.83425035 |
| 136 | Glycosuria (HP:0003076) | 1.83425035 |
| 137 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.83397557 |
| 138 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.83397557 |
| 139 | Septate vagina (HP:0001153) | 1.82380925 |
| 140 | Facial cleft (HP:0002006) | 1.81833020 |
| 141 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.80154974 |
| 142 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.79895402 |
| 143 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.78640916 |
| 144 | Absent epiphyses (HP:0010577) | 1.78640916 |
| 145 | Hyperglycinemia (HP:0002154) | 1.78045396 |
| 146 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.77582073 |
| 147 | Dicarboxylic aciduria (HP:0003215) | 1.77255264 |
| 148 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.77255264 |
| 149 | Cheilitis (HP:0100825) | 1.75561278 |
| 150 | Episodic fever (HP:0001954) | 1.73906620 |
| 151 | Opisthotonus (HP:0002179) | 1.72586889 |
| 152 | Secondary amenorrhea (HP:0000869) | 1.72151132 |
| 153 | Abnormality of serum amino acid levels (HP:0003112) | 1.72037580 |
| 154 | Osteomalacia (HP:0002749) | 1.71818262 |
| 155 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.71483497 |
| 156 | Bone marrow hypocellularity (HP:0005528) | 1.71319378 |
| 157 | Preauricular skin tag (HP:0000384) | 1.69986191 |
| 158 | Patchy hypopigmentation of hair (HP:0011365) | 1.68944080 |
| 159 | Abnormality of the salivary glands (HP:0010286) | 1.68555627 |
| 160 | Angiofibromas (HP:0010615) | 1.68413279 |
| 161 | Adenoma sebaceum (HP:0009720) | 1.68413279 |
| 162 | Abnormality of alanine metabolism (HP:0010916) | 1.68271744 |
| 163 | Hyperalaninemia (HP:0003348) | 1.68271744 |
| 164 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.68271744 |
| 165 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.66753199 |
| 166 | Intestinal fistula (HP:0100819) | 1.66709999 |
| 167 | Abnormality of the duodenum (HP:0002246) | 1.66697266 |
| 168 | Petechiae (HP:0000967) | 1.66098388 |
| 169 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.65544636 |
| 170 | Short thumb (HP:0009778) | 1.64782991 |
| 171 | Myositis (HP:0100614) | 1.63911646 |
| 172 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.63661759 |
| 173 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.63661759 |
| 174 | Hypoglycemic coma (HP:0001325) | 1.62652346 |
| 175 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.62280763 |
| 176 | Partial duplication of the phalanx of hand (HP:0009999) | 1.60852927 |
| 177 | Tetraplegia (HP:0002445) | 1.60740988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.12081693 |
| 2 | CDK12 | 4.59806740 |
| 3 | GRK5 | 3.95773447 |
| 4 | EIF2AK1 | 3.44066385 |
| 5 | ADRBK2 | 3.41000006 |
| 6 | VRK2 | 3.30562704 |
| 7 | CSF1R | 3.07703853 |
| 8 | GRK6 | 3.04120019 |
| 9 | GRK1 | 2.99738080 |
| 10 | FLT3 | 2.93957470 |
| 11 | MST1R | 2.74819985 |
| 12 | PBK | 2.72818684 |
| 13 | SRPK1 | 2.63458511 |
| 14 | TGFBR2 | 2.47794472 |
| 15 | MST4 | 2.32307939 |
| 16 | MATK | 2.29271953 |
| 17 | FRK | 2.21785843 |
| 18 | BCKDK | 2.20353993 |
| 19 | ZAK | 2.00096301 |
| 20 | HIPK2 | 1.99765709 |
| 21 | MAPK7 | 1.82886273 |
| 22 | TRIM28 | 1.81835476 |
| 23 | PRKG2 | 1.77772842 |
| 24 | PASK | 1.70356313 |
| 25 | GRK7 | 1.68108431 |
| 26 | CDK8 | 1.66943690 |
| 27 | KIT | 1.59285499 |
| 28 | PLK4 | 1.58961621 |
| 29 | CDK7 | 1.52863377 |
| 30 | TSSK6 | 1.50446801 |
| 31 | PLK3 | 1.48504261 |
| 32 | LIMK1 | 1.41258346 |
| 33 | NME1 | 1.40473315 |
| 34 | STK16 | 1.37733378 |
| 35 | MOS | 1.35930757 |
| 36 | CCNB1 | 1.35112171 |
| 37 | BUB1 | 1.30013296 |
| 38 | PDK2 | 1.25577934 |
| 39 | MET | 1.24772914 |
| 40 | BRSK2 | 1.21155612 |
| 41 | TLK1 | 1.19807349 |
| 42 | STK10 | 1.17555524 |
| 43 | ZAP70 | 1.14979546 |
| 44 | MAPK15 | 1.13646532 |
| 45 | NME2 | 1.13031157 |
| 46 | FGFR3 | 1.10927690 |
| 47 | TTK | 1.07978973 |
| 48 | TEC | 1.03871267 |
| 49 | BTK | 1.02987115 |
| 50 | ERBB3 | 1.02442459 |
| 51 | PIM2 | 1.00012265 |
| 52 | MYLK | 0.98818360 |
| 53 | VRK1 | 0.98599262 |
| 54 | PAK4 | 0.98545583 |
| 55 | CDK19 | 0.97102050 |
| 56 | ILK | 0.96502660 |
| 57 | TESK2 | 0.95372444 |
| 58 | RPS6KB2 | 0.94033141 |
| 59 | NTRK1 | 0.93629121 |
| 60 | CAMK4 | 0.93158498 |
| 61 | SCYL2 | 0.90727970 |
| 62 | MAPKAPK3 | 0.89431564 |
| 63 | CSNK1G3 | 0.89059435 |
| 64 | DAPK1 | 0.87774953 |
| 65 | SIK3 | 0.86206600 |
| 66 | TAF1 | 0.85907219 |
| 67 | MUSK | 0.85118770 |
| 68 | PLK1 | 0.85092391 |
| 69 | TAOK3 | 0.80744847 |
| 70 | LMTK2 | 0.80666777 |
| 71 | ADRBK1 | 0.80051456 |
| 72 | IRAK3 | 0.80029232 |
| 73 | MAP2K6 | 0.79846476 |
| 74 | PRKD3 | 0.79607895 |
| 75 | NEK2 | 0.78450724 |
| 76 | SMG1 | 0.77880602 |
| 77 | CHEK2 | 0.76874460 |
| 78 | WEE1 | 0.74766836 |
| 79 | MAP4K1 | 0.73377044 |
| 80 | INSRR | 0.71463721 |
| 81 | CAMKK2 | 0.70669616 |
| 82 | STK39 | 0.70380063 |
| 83 | BRSK1 | 0.69910205 |
| 84 | TGFBR1 | 0.69837351 |
| 85 | LRRK2 | 0.69699896 |
| 86 | CDC7 | 0.68621582 |
| 87 | CSNK1G1 | 0.67844463 |
| 88 | PNCK | 0.67355297 |
| 89 | ITK | 0.66756196 |
| 90 | DYRK3 | 0.65768767 |
| 91 | EIF2AK3 | 0.64087225 |
| 92 | STK4 | 0.63680996 |
| 93 | CSNK1A1L | 0.63435583 |
| 94 | MAP3K12 | 0.60546947 |
| 95 | ACVR1B | 0.60247964 |
| 96 | TYRO3 | 0.59248063 |
| 97 | WNK1 | 0.59231501 |
| 98 | PRKCI | 0.57710303 |
| 99 | SYK | 0.57680264 |
| 100 | CDK9 | 0.55870108 |
| 101 | MAP3K8 | 0.54329690 |
| 102 | ABL2 | 0.53941159 |
| 103 | SIK1 | 0.53034507 |
| 104 | EPHB2 | 0.52914157 |
| 105 | NUAK1 | 0.52512848 |
| 106 | TNIK | 0.51046376 |
| 107 | JAK3 | 0.49954967 |
| 108 | BMPR1B | 0.49588510 |
| 109 | MINK1 | 0.49251265 |
| 110 | ATM | 0.48664461 |
| 111 | EPHA2 | 0.48474701 |
| 112 | ATR | 0.47987332 |
| 113 | FER | 0.47842399 |
| 114 | DYRK1B | 0.47713010 |
| 115 | CSNK2A1 | 0.46439095 |
| 116 | MAP2K4 | 0.46418039 |
| 117 | AKT3 | 0.45293984 |
| 118 | ERBB4 | 0.44138280 |
| 119 | CSNK2A2 | 0.43529830 |
| 120 | BCR | 0.43083521 |
| 121 | CDK18 | 0.42536375 |
| 122 | TESK1 | 0.42370092 |
| 123 | DAPK3 | 0.40924646 |
| 124 | CDK14 | 0.40907336 |
| 125 | TNK2 | 0.39994807 |
| 126 | MAP3K3 | 0.39842781 |
| 127 | PRKCD | 0.39083243 |
| 128 | PTK2 | 0.39050041 |
| 129 | AKT2 | 0.38916383 |
| 130 | MARK2 | 0.38816637 |
| 131 | NEK1 | 0.38581523 |
| 132 | RPS6KA5 | 0.37823396 |
| 133 | IGF1R | 0.37436619 |
| 134 | KDR | 0.36749392 |
| 135 | PAK1 | 0.36745186 |
| 136 | CDK15 | 0.36453206 |
| 137 | CSNK1G2 | 0.36427304 |
| 138 | PIK3CG | 0.35230592 |
| 139 | TRIB3 | 0.35164924 |
| 140 | AURKB | 0.34057522 |
| 141 | IKBKB | 0.32820659 |
| 142 | CDK1 | 0.32672844 |
| 143 | CDK11A | 0.32366738 |
| 144 | MAP3K10 | 0.31159523 |
| 145 | EIF2AK2 | 0.30320436 |
| 146 | AURKA | 0.30097948 |
| 147 | RPS6KA4 | 0.29949873 |
| 148 | MKNK1 | 0.29461330 |
| 149 | MAPK4 | 0.28969830 |
| 150 | TIE1 | 0.28747563 |
| 151 | MAPKAPK5 | 0.28632391 |
| 152 | CAMK2D | 0.28439688 |
| 153 | BRAF | 0.28156035 |
| 154 | EEF2K | 0.27955634 |
| 155 | CHEK1 | 0.27491133 |
| 156 | LYN | 0.26246711 |
| 157 | PKN2 | 0.25896034 |
| 158 | PRKD2 | 0.24628957 |
| 159 | NLK | 0.24455992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.36251485 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.27549479 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.23055457 |
| 4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.17606977 |
| 5 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.15191580 |
| 6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.06787231 |
| 7 | Galactose metabolism_Homo sapiens_hsa00052 | 3.00853077 |
| 8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.69479471 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.69201806 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.37493460 |
| 11 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.28205622 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 2.22908690 |
| 13 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.20448106 |
| 14 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.16948777 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.13793873 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.05754784 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 2.01286979 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.00631205 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.92798893 |
| 20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.92704734 |
| 21 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.89754840 |
| 22 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.84683687 |
| 23 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.78039218 |
| 24 | Homologous recombination_Homo sapiens_hsa03440 | 1.77200099 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.76670601 |
| 26 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.74144349 |
| 27 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.60014607 |
| 28 | Thyroid cancer_Homo sapiens_hsa05216 | 1.55264927 |
| 29 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.49614916 |
| 30 | Huntingtons disease_Homo sapiens_hsa05016 | 1.44291325 |
| 31 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.35451541 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.29759575 |
| 33 | Cell cycle_Homo sapiens_hsa04110 | 1.28997382 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.27705010 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.27377502 |
| 36 | RNA degradation_Homo sapiens_hsa03018 | 1.27114253 |
| 37 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.26912369 |
| 38 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.23977498 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.22601605 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.22517971 |
| 41 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.21800637 |
| 42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.21486062 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.19050705 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.17580677 |
| 45 | RNA transport_Homo sapiens_hsa03013 | 1.13284896 |
| 46 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11256104 |
| 47 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.10525541 |
| 48 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.06791214 |
| 49 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.03609707 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 1.02768066 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.01810009 |
| 52 | RNA polymerase_Homo sapiens_hsa03020 | 0.99950836 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98439447 |
| 54 | Spliceosome_Homo sapiens_hsa03040 | 0.98027567 |
| 55 | Proteasome_Homo sapiens_hsa03050 | 0.97068485 |
| 56 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.95958227 |
| 57 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.92691897 |
| 58 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.90622955 |
| 59 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.89886075 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.89590783 |
| 61 | Lysosome_Homo sapiens_hsa04142 | 0.88789529 |
| 62 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.88346221 |
| 63 | Purine metabolism_Homo sapiens_hsa00230 | 0.87167360 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86627040 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.85812914 |
| 66 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.82055262 |
| 67 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.78773745 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 0.78702080 |
| 69 | Basal transcription factors_Homo sapiens_hsa03022 | 0.77673161 |
| 70 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.76722328 |
| 71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.75089976 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72159770 |
| 73 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.71774687 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.71137865 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70640536 |
| 76 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.70051462 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67850719 |
| 78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.67818764 |
| 79 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63010265 |
| 80 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.62387844 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61615758 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60699755 |
| 83 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60486204 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60007255 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59628656 |
| 86 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59100845 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59070918 |
| 88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58561272 |
| 89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.58500921 |
| 90 | Peroxisome_Homo sapiens_hsa04146 | 0.56575466 |
| 91 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54495841 |
| 92 | Alcoholism_Homo sapiens_hsa05034 | 0.52104995 |
| 93 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.52050908 |
| 94 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51752335 |
| 95 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.50091146 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49669022 |
| 97 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.49233941 |
| 98 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48996167 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48152015 |
| 100 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.45954940 |
| 101 | ABC transporters_Homo sapiens_hsa02010 | 0.44708112 |
| 102 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.43769747 |
| 103 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.41370177 |
| 104 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.38963753 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38911377 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.36291470 |
| 107 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35458616 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.33528843 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31513610 |
| 110 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.29173333 |
| 111 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.28789757 |
| 112 | Bladder cancer_Homo sapiens_hsa05219 | 0.27560694 |
| 113 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.27233480 |
| 114 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.26994094 |
| 115 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.26751811 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25084263 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23722625 |
| 118 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.23337160 |
| 119 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.23029765 |
| 120 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.22987419 |
| 121 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.22419872 |
| 122 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.22034822 |
| 123 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.18467113 |
| 124 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.17089323 |
| 125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16777078 |
| 126 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.16163871 |
| 127 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.15376661 |
| 128 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.14948795 |
| 129 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.14431714 |
| 130 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.12962119 |
| 131 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.12737476 |
| 132 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.11474707 |
| 133 | Apoptosis_Homo sapiens_hsa04210 | 0.11079501 |
| 134 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.10539682 |
| 135 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.09780461 |
| 136 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.08280527 |

